SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share (SLNO)

Historical Holders from Q3 2022 to Q3 2025

Symbol
SLNO on Nasdaq
Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
53.6M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
65.2M
Holdings value
$4.4B
% of all portfolios
0.014%
Grand Portfolio weight change
+0.001%
Number of holders
234
Number of buys
166
Number of sells
-102
Average Value change %
0%
Average buys %
+0.005%
Average sells %
-0.007%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share (SLNO)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 15% +120% $679M $390M 7.83M +135% FMR LLC 31 Jul 2025
JANUS HENDERSON GROUP PLC 11.4% +8.18% $409M $50.6M 6.06M +14.1% JANUS HENDERSON GROUP PLC 30 Sep 2025
PRICE T ROWE ASSOCIATES INC /MD/ 6.9% +34% $300M $91.9M 3.46M +44.2% T. Rowe Price Associates, Inc. 30 Jun 2025
VANGUARD GROUP INC 5.28% $190M 2.81M The Vanguard Group 30 Sep 2025
ADAGE CAPITAL PARTNERS GP, L.L.C. 6.44% $204M 2.78M Adage Capital Management, L.P. 31 Dec 2024
BlackRock, Inc. 5.5% +16% $232M $63.4M 2.77M +37.6% BlackRock, Inc. 30 Jun 2025
Vivo Opportunity Fund Holdings, L.P. 4.2% -45.7% $152M -$115M 2.25M -43.1% Vivo Opportunity Fund Holdings, L.P. 30 Sep 2025
Avoro Capital Advisors LLC 4.1% $178M 2.05M Avoro Capital Advisors LLC 30 Jun 2025
Adage Capital Management, L.P. 2.64% -63.7% $94.7M -$147M 1.4M -60.8% Adage Capital Management, L.P. 30 Sep 2025
Nantahala Capital Management, LLC 1.99% -60.2% $86.8M -$141M 1M -61.9% Nantahala Capital Management, LLC 30 Jun 2025

Institutional Holders of SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share (SLNO)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 65.2M $4.4B +$507M $67.60 234
2025 Q2 56.7M $4.75B +$213M $83.78 231
2025 Q1 54.6M $3.9B +$305M $71.45 215
2024 Q4 51M $2.29B +$170M $44.95 164
2024 Q3 47.1M $2.38B +$200M $50.49 140
2024 Q2 43.3M $1.77B +$339M $40.80 112
2024 Q1 35M $1.5B +$153M $42.80 97
2023 Q4 31.4M $1.26B +$429M $40.25 76
2023 Q3 20.3M $599M +$451M $29.51 54
2023 Q2 4.85M $20.8M +$7.84M $4.29 22
2023 Q1 3.07M $6.54M +$3.16M $2.14 20
2022 Q4 2.79M $5.52M +$81.6K $1.98 22
2022 Q3 2.78M $4.65M +$4.63M $1.67 14